Logo image of BRBR

BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis

NYSE:BRBR - New York Stock Exchange, Inc. - US07831C1036 - Common Stock - Currency: USD

72.97  -1.19 (-1.6%)

After market: 72.97 0 (0%)

Fundamental Rating

6

BRBR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. While BRBR has a great profitability rating, there are some minor concerns on its financial health. BRBR is valued quite expensive, but it does show an excellent growth. This makes BRBR very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

BRBR had positive earnings in the past year.
In the past year BRBR had a positive cash flow from operations.
BRBR had positive earnings in each of the past 5 years.
In the past 5 years BRBR always reported a positive cash flow from operatings.
BRBR Yearly Net Income VS EBIT VS OCF VS FCFBRBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

BRBR has a Return On Assets of 31.57%. This is amongst the best in the industry. BRBR outperforms 100.00% of its industry peers.
BRBR has a better Return On Invested Capital (46.63%) than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 13.42%.
The last Return On Invested Capital (46.63%) for BRBR is above the 3 year average (38.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 31.57%
ROE N/A
ROIC 46.63%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
BRBR Yearly ROA, ROE, ROICBRBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

BRBR has a Profit Margin of 13.32%. This is amongst the best in the industry. BRBR outperforms 91.67% of its industry peers.
In the last couple of years the Profit Margin of BRBR has declined.
With an excellent Operating Margin value of 20.49%, BRBR belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
BRBR's Operating Margin has been stable in the last couple of years.
BRBR has a worse Gross Margin (36.16%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of BRBR has remained more or less at the same level.
Industry RankSector Rank
OM 20.49%
PM (TTM) 13.32%
GM 36.16%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
BRBR Yearly Profit, Operating, Gross MarginsBRBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRBR is creating value.
The number of shares outstanding for BRBR has been reduced compared to 1 year ago.
Compared to 5 years ago, BRBR has more shares outstanding
The debt/assets ratio for BRBR has been reduced compared to a year ago.
BRBR Yearly Shares OutstandingBRBR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRBR Yearly Total Debt VS Total AssetsBRBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BRBR has an Altman-Z score of 10.33. This indicates that BRBR is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 10.33, BRBR belongs to the best of the industry, outperforming 86.11% of the companies in the same industry.
The Debt to FCF ratio of BRBR is 6.64, which is on the high side as it means it would take BRBR, 6.64 years of fcf income to pay off all of its debts.
BRBR has a Debt to FCF ratio (6.64) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.64
Altman-Z 10.33
ROIC/WACC5.33
WACC8.75%
BRBR Yearly LT Debt VS Equity VS FCFBRBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

2.3 Liquidity

A Current Ratio of 3.35 indicates that BRBR has no problem at all paying its short term obligations.
BRBR's Current ratio of 3.35 is amongst the best of the industry. BRBR outperforms 83.33% of its industry peers.
BRBR has a Quick Ratio of 1.55. This is a normal value and indicates that BRBR is financially healthy and should not expect problems in meeting its short term obligations.
BRBR's Quick ratio of 1.55 is fine compared to the rest of the industry. BRBR outperforms 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 3.35
Quick Ratio 1.55
BRBR Yearly Current Assets VS Current LiabilitesBRBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

7

3. Growth

3.1 Past

BRBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.48%, which is quite impressive.
BRBR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.29% yearly.
Looking at the last year, BRBR shows a very strong growth in Revenue. The Revenue has grown by 21.00%.
The Revenue has been growing by 18.50% on average over the past years. This is quite good.
EPS 1Y (TTM)46.48%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%34.88%
Revenue 1Y (TTM)21%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%23.82%

3.2 Future

The Earnings Per Share is expected to grow by 14.17% on average over the next years. This is quite good.
Based on estimates for the next years, BRBR will show a quite strong growth in Revenue. The Revenue will grow by 10.06% on average per year.
EPS Next Y18.53%
EPS Next 2Y16.21%
EPS Next 3Y16.28%
EPS Next 5Y14.17%
Revenue Next Year15.7%
Revenue Next 2Y13.31%
Revenue Next 3Y12.6%
Revenue Next 5Y10.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BRBR Yearly Revenue VS EstimatesBRBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BRBR Yearly EPS VS EstimatesBRBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 35.08 indicates a quite expensive valuation of BRBR.
Compared to the rest of the industry, the Price/Earnings ratio of BRBR is on the same level as its industry peers.
BRBR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 28.00 indicates a quite expensive valuation of BRBR.
BRBR's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, BRBR is valued a bit more expensive.
Industry RankSector Rank
PE 35.08
Fwd PE 28
BRBR Price Earnings VS Forward Price EarningsBRBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BRBR's Enterprise Value to EBITDA ratio is in line with the industry average.
BRBR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 74.59
EV/EBITDA 22.96
BRBR Per share dataBRBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BRBR has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BRBR's earnings are expected to grow with 16.28% in the coming years.
PEG (NY)1.89
PEG (5Y)N/A
EPS Next 2Y16.21%
EPS Next 3Y16.28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BRBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELLRING BRANDS INC

NYSE:BRBR (2/21/2025, 8:04:09 PM)

After market: 72.97 0 (0%)

72.97

-1.19 (-1.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)N/A N/A
Inst Owners98.12%
Inst Owner Change0.76%
Ins Owners1.49%
Ins Owner Change12.53%
Market Cap9.36B
Analysts82.86
Price Target87.72 (20.21%)
Short Float %1.4%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.7%
Min EPS beat(2)0.44%
Max EPS beat(2)18.96%
EPS beat(4)4
Avg EPS beat(4)17.57%
Min EPS beat(4)0.44%
Max EPS beat(4)31.81%
EPS beat(8)8
Avg EPS beat(8)12.46%
EPS beat(12)12
Avg EPS beat(12)14.03%
EPS beat(16)15
Avg EPS beat(16)14.85%
Revenue beat(2)1
Avg Revenue beat(2)0.56%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)1.64%
Revenue beat(4)2
Avg Revenue beat(4)1.15%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)3.78%
Revenue beat(8)5
Avg Revenue beat(8)1.27%
Revenue beat(12)7
Avg Revenue beat(12)0.13%
Revenue beat(16)9
Avg Revenue beat(16)0.85%
PT rev (1m)0.61%
PT rev (3m)23.2%
EPS NQ rev (1m)8.94%
EPS NQ rev (3m)40.09%
EPS NY rev (1m)2.91%
EPS NY rev (3m)6.25%
Revenue NQ rev (1m)1.64%
Revenue NQ rev (3m)10.83%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)4.27%
Valuation
Industry RankSector Rank
PE 35.08
Fwd PE 28
P/S 4.46
P/FCF 74.59
P/OCF 72.9
P/B N/A
P/tB N/A
EV/EBITDA 22.96
EPS(TTM)2.08
EY2.85%
EPS(NY)2.61
Fwd EY3.57%
FCF(TTM)0.98
FCFY1.34%
OCF(TTM)1
OCFY1.37%
SpS16.36
BVpS-1.14
TBVpS-2.73
PEG (NY)1.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 31.57%
ROE N/A
ROCE 62.2%
ROIC 46.63%
ROICexc 50.23%
ROICexgc 73.56%
OM 20.49%
PM (TTM) 13.32%
GM 36.16%
FCFM 5.98%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score7
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.64
Debt/EBITDA 1.86
Cap/Depr 15.68%
Cap/Sales 0.14%
Interest Coverage 250
Cash Conversion 28.63%
Profit Quality 44.9%
Current Ratio 3.35
Quick Ratio 1.55
Altman-Z 10.33
F-Score7
WACC8.75%
ROIC/WACC5.33
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)46.48%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%34.88%
EPS Next Y18.53%
EPS Next 2Y16.21%
EPS Next 3Y16.28%
EPS Next 5Y14.17%
Revenue 1Y (TTM)21%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%23.82%
Revenue Next Year15.7%
Revenue Next 2Y13.31%
Revenue Next 3Y12.6%
Revenue Next 5Y10.06%
EBIT growth 1Y50.61%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year22.2%
EBIT Next 3Y15.64%
EBIT Next 5Y12.79%
FCF growth 1Y93.37%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y93.37%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%